| Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). (NCT05038657) | University Hospital Southampton NHS Foundation Trust | 2022-05-30 |
| Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis (NCT05202860) | Merete Haedersdal | 2022-05-09 |
| Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms (NCT05402046) | MelanomaPRO, Russia | 2022-04-23 |
| Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma (NCT05854030) | Tianjin Medical University Cancer Institute and Hospital | 2022-04-01 |
| A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China (NCT05337163) | Creative Biosciences (Guangzhou) Co., Ltd. | 2022-02-25 |
| Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population (NCT05863052) | University of Oklahoma | 2022-01-31 |
| A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT (NCT05125354) | Alpha Tau Medical LTD. | 2022-01-06 |
| Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery (NCT04391049) | NRG Oncology | 2021-12-02 |
| Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA) (NCT05027633) | M.D. Anderson Cancer Center | 2021-11-02 |
| Needs and Preferences of Patients With Head-neck Cutaneous SCC (NCT06046625) | Maastricht University Medical Center | 2021-11-01 |
| Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck (NCT05108090) | Indiana University | 2021-10-25 |
| Study of PF-07263689 in Participants With Selected Advanced Solid Tumors (NCT05061537) | Pfizer | 2021-10-20 |
| Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma (NCT05070403) | H. Lee Moffitt Cancer Center and Research Institute | 2021-10-01 |
| Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease (NCT05048459) | Memorial Sloan Kettering Cancer Center | 2021-09-01 |
| Study of the Association Between Tumor Microenvironment Macrophages and Treatment Response in Squamous Cell Carcinoma of the Anal Canal (NCT05019235) | Fondation Hôpital Saint-Joseph | 2021-08-05 |
| Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT05007613) | National Taiwan University Hospital | 2021-06-23 |
| Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo (NCT04969419) | Momentum Data | 2021-06-18 |
| Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC) (NCT04808999) | Diwakar Davar | 2021-05-11 |
| Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp (NCT05987579) | Maastricht University Medical Center | 2021-05-03 |
| Combination 5-FU / Calcipotriene Cream for SCCIS/SCC (NCT04839731) | Carilion Clinic | 2021-04-14 |
| Rigosertib for RDEB-SCC (NCT03786237) | Prof. Johann Bauer | 2021-04-12 |
| T1 Squamous Cell Carcinomas of the Lip (NCT05610293) | Maastricht University Medical Center | 2021-04-01 |
| Spectroscopic Analysis of Tongue Tumor Samples. (NCT05104619) | Centre Hospitalier Universitaire, Amiens | 2021-03-10 |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells (NCT04628806) | Charite University, Berlin, Germany | 2021-02-17 |
| DNX-2440 for Resectable Colorectal Liver Metastasis (NCT04714983) | DNAtrix, Inc. | 2021-02-15 |
| Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line (NCT03292822) | Cairo University | 2021-02-15 |
| Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT04922450) | Hunan Cancer Hospital | 2021-01-20 |
| Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers (NCT04738786) | Samsung Medical Center | 2021-01-18 |
| Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer (NCT04410874) | Ivan Litvinov | 2020-11-16 |
| Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN) (NCT04606940) | University Health Network, Toronto | 2020-10-19 |
| A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers (NCT04260802) | Ocellaris Pharma, Inc. | 2020-09-24 |
| A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (NCT04370587) | ImmVira Pharma Co. Ltd | 2020-09-17 |
| A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck (NCT04435938) | McMaster University | 2020-09-10 |
| Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT (NCT04685798) | Washington University School of Medicine | 2020-09-02 |
| A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma (NCT04533321) | National University Hospital, Singapore | 2020-09-01 |
| A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors (NCT04442126) | Numab Therapeutics AG | 2020-08-19 |
| HRQoL Keratinocyte Carcinomas (NCT04814953) | University Hospital, Ghent | 2020-07-01 |
| Skin Tumor Biomarkers by Mass Spectrometry Imaging (NCT06227416) | Bispebjerg Hospital | 2020-06-15 |
| Dose Optimized BNCT for Head and Neck Cancer (NCT05883007) | Southern Tohoku BNCT Research Center | 2020-06-01 |
| Prognostic Immune Biomarkers in HNSCC (NCT05941676) | University Hospital Ostrava | 2020-06-01 |
| Epigenetic Changes in Head and Neck Cancer (NCT04260074) | Aalborg University Hospital | 2020-03-11 |
| 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck (NCT04150900) | University of Maryland, Baltimore | 2020-01-13 |
| Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC) (NCT03875859) | Kavita Sarin | 2019-12-12 |
| De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer (NCT03952585) | National Cancer Institute (NCI) | 2019-10-09 |
| A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer (NCT04099446) | ProgenaBiome | 2019-10-01 |
| Early Diagnosis of Upper Digestive Tract Disease (NCT04475952) | Imperial College London | 2019-09-13 |
| De-Escalation Therapy for Human Papillomavirus Negative Disease (NCT03944915) | University of Chicago | 2019-08-26 |
| IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma (NCT03381183) | H. Lee Moffitt Cancer Center and Research Institute | 2019-08-21 |
| A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors (NCT03982212) | University of Kansas Medical Center | 2019-07-26 |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage (NCT04688749) | Aristotle University Of Thessaloniki | 2019-07-17 |
| Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy (NCT04106167) | Fate Therapeutics | 2019-06-11 |
| Cetuximab in Head and Neck Cancer Patients (NCT03769311) | University of Wisconsin, Madison | 2019-04-17 |
| Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck (NCT03854032) | Thomas Jefferson University | 2019-04-09 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer (NCT03802058) | Wuhan University | 2019-03-20 |
| Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck (NCT03708224) | Alain Algazi | 2019-03-08 |
| Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma (NCT03719924) | Federation Francophone de Cancerologie Digestive | 2019-03-07 |
| FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors (NCT03841110) | Fate Therapeutics | 2019-02-15 |
| IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors (NCT03758781) | H. Lee Moffitt Cancer Center and Research Institute | 2019-02-13 |
| Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis. (NCT03837613) | Mohamed Ghorab | 2019-02-01 |
| Surgery Plus Intraoperative Radiotherapy as Treatment for Squamous Cell Carcinoma Over Pilonidal Disease. (NCT04201002) | Hospital Provincial de Castellon | 2019-02-01 |
| PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma (NCT03791905) | Mian XI | 2019-01-15 |
| Study of TVEC in Patients With Cutaneous Squamous Cell Cancer (NCT03714828) | University of Arizona | 2018-12-20 |
| M6620 Plus Standard Treatment in Oesophageal and Other Cancer (NCT03641547) | University of Oxford | 2018-12-04 |
| Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT03652233) | Vanderbilt-Ingram Cancer Center | 2018-11-02 |
| TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck (NCT03729518) | Abramson Cancer Center at Penn Medicine | 2018-10-11 |
| Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC (NCT03636685) | Chinese Academy of Medical Sciences | 2018-08-15 |
| EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer (NCT03494322) | University College, London | 2018-07-20 |
| IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas (NCT04224389) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-06-22 |
| Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia (NCT03476330) | Children's Hospital Medical Center, Cincinnati | 2018-05-08 |
| PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients (NCT03342378) | University of Wisconsin, Madison | 2018-05-03 |
| T-VEC in Non-melanoma Skin Cancer (NCT03458117) | University of Zurich | 2018-04-19 |
| Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma (NCT03486509) | Fujian Cancer Hospital | 2018-04-01 |
| QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed (NCT03387111) | ImmunityBio, Inc. | 2018-01-09 |
| Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy (NCT03223662) | National Cancer Institute (NCI) | 2017-10-31 |
| Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629) (NCT03284424) | Merck Sharp & Dohme LLC | 2017-10-26 |
| Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer (NCT03215810) | H. Lee Moffitt Cancer Center and Research Institute | 2017-10-11 |
| PEN-866 in Patients With Advanced Solid Malignancies (NCT03221400) | Tarveda Therapeutics | 2017-08-29 |
| Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers (NCT03190174) | Sarcoma Oncology Research Center, LLC | 2017-08-24 |
| PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck (NCT02819752) | Royal Marsden NHS Foundation Trust | 2017-07-12 |
| Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer (NCT03579004) | Mona Frolova | 2017-07-10 |
| A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp (NCT03115476) | LEO Pharma | 2017-06-16 |
| Molecular Characterization of Cutaneous Tumors (NCT03092830) | Rabin Medical Center | 2017-03-29 |
| Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (NCT03015883) | Alpha Tau Medical LTD. | 2017-02-22 |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (NCT03058289) | Intensity Therapeutics, Inc. | 2017-02-09 |
| Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ (NCT03025724) | Rhode Island Hospital | 2017-01-01 |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer (NCT02410603) | Mayo Clinic | 2016-12-01 |
| Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma (NCT02943044) | Zenalux Biomedical, Inc. | 2016-12-01 |
| Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo (NCT02902822) | Centro Studi Gised | 2016-10-01 |
| Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides (NCT02890368) | Pfizer | 2016-09-01 |
| Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma (NCT02298595) | Julie E. Bauman, MD, MPH | 2016-08-01 |
| Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue (NCT02985255) | HealthCare Global Enterprise Ltd. | 2016-04-01 |
| Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck (NCT02776137) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2016-03-01 |
| Strategies to Promote Skin Health (NCT03237013) | San Diego State University | 2016-02-18 |
| Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers (NCT03162042) | University Hospital, Clermont-Ferrand | 2015-11-02 |
| Pembrolizumab in Combination With CRT for LA-SCCHN (NCT02586207) | Sanford Health | 2015-11-01 |
| Using MC1R Genotype to Impact Melanoma Risk Behavior (NCT03509467) | H. Lee Moffitt Cancer Center and Research Institute | 2015-08-03 |
| Utility of the Skin Cancer Quality of Life Impact Tool (NCT02580916) | Oxford University Hospitals NHS Trust | 2015-07-01 |
| The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial (NCT02394652) | University Health Network, Toronto | 2015-05-21 |
| EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds (NCT02409628) | Neotherix Limited | 2015-04-23 |